My research encompasses various therapeutic approaches, including the development of novel antibacterials, repurposing FDA-approved molecules, and the synthesis of hybrid molecules targeting pathogenic bacterial agents. Primarily, my work revolves around infectious diseases and the pursuit of innovative therapeutics against bacterial pathogens.

During my career development journey, I received training in India, South Korea, and the USA. In particular, I honed my expertise in medical bacteriology and biomedical science at Yonsei University in South Korea (ranked #3 in South Korea, 76 worldwide) and conducted my dissertation on novel therapeutics against H. pylori-induced gastric cancer. After obtaining my Ph.D., I joined Rhode Island Hospital and The Miriam Hospital for my Postdoctoral studies. During this period, my research focused on antibacterial therapies and the use of vertebrate and invertebrate infection models in the Mylonakis laboratory.

Following my Postdoc, I joined as an Instructor of Medicine at Brown University (ranked #60 worldwide) and research scientist at The Miriam Hospital, where I led projects as Principal Investigator. Starting in March 2024, I have been working as an Assistant Research Professor of Medicine at Houston Methodist Academic Institute.

To date, my research efforts have resulted in 35 peer-reviewed publications, including articles in reputable journals such as ACS Nano, Carbohydrate Polymers, Future Medicinal Chemistry, Frontiers in Microbiology, Antimicrobial Agents and Chemotherapy, and Scientific Reports. My research encompasses a wide range of activities, including screening, compound discovery, target validation, and exploration of lead compounds. Throughout my years of training, I have gained extensive experience working with medically important microbial pathogens, including Helicobacter pylori and Staphylococcus aureus, using in vivo murine infection models.